Regencell Bioscience Holdings Ltd is 3.3x more valuable than Curaleaf Holdings, Inc. by market capitalization ($9.34 B vs $2.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CURLF | RGC |
|---|---|---|
| Market cap | $2.85 B | $9.34 B |
| US-listed rank | #1848 | #983 |
| Revenue (latest FY) | $1.27B | - |
| Net income (latest FY) | -$231.07M | -$3.58M |
| Net margin | -18.2% | - |
| SEC filings | 176 | 82 |
Regencell Bioscience Holdings Ltd is 3.3x more valuable than Curaleaf Holdings, Inc. by market capitalization ($9.34 B vs $2.85 B).
Full pages: Curaleaf Holdings, Inc. and Regencell Bioscience Holdings Ltd, or browse the full rankings.